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ROUTINE USE OF ANTIMICROBIAL DRUGS DURING THE 2004
CHOLERA EPIDEMIC IN DOUALA, CAMEROON
J. NOESKE, E. GUÉVART, C. KUABAN, J. SOLLE, M-C. FONKOUA, A. MOUANGUE and A.B. FOUDA
ABSTRACT
Objectives: To evaluate routine use of antimicrobial drugs for treatment and prevention of cholera
with special regards to the evolution of the antimicrobial drug resistance patterns of V. cholerae  strains.
Design: Retrospective population-based descriptive study.
Subjects: Four thousand nine hundred and forty one notified cholera cases, their 15,381 patients’
guards and their 159,263 household members and close neighbours.
Results: A total of 4,941 patients received antibiotic therapy according to the treatment protocols.
Prophylactic treatment was administered to 15,381 patients’ guards in hospitals and to 159,263
household members and close neighbours during home visits. Over the entire outbreak, the
antimicrobial susceptibility patterns of V. cholerae strains isolated remained stable.
Conclusions: The routine use of antimicrobial therapy for cholera cases associated with simultaneous
and large scale chemoprophylaxis of close contacts does not seem in our experience to compromise
the stability of V. cholerae susceptibility profiles to drugs when applied within a comprehensive
package of rigorously monitored community interventions. The role of therapy and
chemoprophylaxis in limiting the extent of a cholera epidemic is however difficult to ascertain
from our experience. Field trials need to be designed to elucidate this aspect.
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INTRODUCTION
A general rule stipulates that prolonged use of the
same antibiotic should be avoided and that for
prevention another antibiotic than the one
administered for curative care should be used, all
in a bid to avoid the emergence of resistant bacterial
strains (1). Vibrio cholerae, a Gram-negative bacillus,
is usually susceptible to various antibiotics. In
cholera treatment, antimicrobial therapy can
shorten the faecal excretion of V. cholerae and lessen
diarrhoeal purging (2). There is also evidence that
healthy cholera carriers may play a role in the
transmission of cholera infection and that cholera
contacts preventively treated may result in a
reduction in the disease incidence (3). Prophylactic
antibiotics given to cholera contacts may therefore
limit the spread of an epidemic. In various settings,
however, mass prevention with antimicrobial
therapy dispensed during cholera epidemics
seemed to have provoked the emergence of
resistant strains of V. cholerae (4,5). As such,
strategies for the control of cholera outbreaks as
recommended by the World Health Organisation
(WHO) do not include the use of antibiotics for
mass prophylaxis (6).
November 2006 E A S T  A F R I C A N  M E D I C A L  J O U R N A L 597
In early January 2004, cases of severe watery
diarrhoea were reported in Douala, the economic
capital of Cameroon with an estimated population
of 2.4 million inhabitants. The first three stool
samples of patients examined at Centre Pasteur du
Cameroun (CPC), the country’s National Reference
Laboratory, grew V. cholerae serogroup 01, later
identified by Institut Pasteur in Paris, France, as
serotype Inaba. Antimicrobial susceptibility testing
of these strains revealed that they were resistant to
trimethoprim-sulfamethoxazole and colistine but
susceptible to amoxicillin and doxycycline. An
outbreak of cholera which lasted about eight months
was declared by the country’s health authorities.
In order to control the epidemic, a task force was
set up at provincial level to plan and coordinate the
various interventions to be applied. Strategies
adopted by the task force included opening of
cholera treatment units (CTU) in Douala hospitals,
use of standardised treatment protocols including
routine use of antimicrobial drugs and preventive
treatment of contacts. In this paper we report our
experience with routine use of antimicrobial drugs
for treatment and prevention of cholera with special
regards to the evolution of the antimicrobial
resistance patterns of V. cholerae strains isolated
during this 2004 cholera epidemic in Douala.
MATERIALS AND METHODS
Fourteen CTUs in hospitals equally distributed over
the town of Douala were instructed by the task force
to directly admit and treat free of charge any person
who presented with symptoms suggestive of
cholera. The diagnosis of cholera was made on
clinical grounds according to WHO (6)
recommendations by each physician in charge of a
CTU. Treatment management protocols including
rehydration and systematic prescription of
antimicrobial therapy have already been described
elsewhere by Guévart et al (7,8). Taking into
consideration (a) the antimicrobial susceptibility
patterns of the V. cholerae  strains isolated at the onset
of the epidemic; (b) the fact that a single dose of
doxycycline has been shown to reduce diarrhoeal
discharge by patients as well as reduce cholera
infection in contacts (9); (c) the possibility that
treatment compliance could be ensured by a single
dose or a short course regimen of antibiotherapy;
and (d) the availability and tolerance as welI as low
cost of drugs to be prescribed, it was decided that
doxycycline or amoxicillin will be administered for
therapy as well as for prevention. Antibiotics were
administrated orally to patients as soon as vomiting
ceased. A single dose of doxycycline at 5mg/kg body
weight was administered when there was no contra-
indication. Amoxicillin at 50 mg/kg body weight
divided into three daily doses for three consecutive
days was prescribed to pregnant or breastfeeding
women and patients aged eight years or less. When
a pregnant woman presented with persisting
vomiting, oral amoxicillin was initially replaced by
injectable ampicillin. Patients’ characteristics and
treatments received by them were recorded in
cholera treatment unit registers and on individual
patients’ treatment cards.
The antibiotic treatment regimens were as well
systematically given as prophylaxis to patients’
guards (i.e. family members taking care of their
patients in hospital). Furthermore during systematic
home visits to disinfect patients’ homes and provide
health education, all household members and close
neighbours defined as people living directly in
adjacent houses to the patients were equally given
the same prophylaxis. Characteristics of persons
treated prophylactically were recorded on adapted
forms. Tight daily monitoring of the CTUs by
supervisors and daily field visits ensured that
diagnostic and curative algorithms as well as rules
for prescribing and administering prophylaxis were
correctly applied.
To ascertain the correctness of the diagnosis and
thus the persistence of the cholera epidemic as well
as monitor changes in the patterns of drug resistance
of the V. cholerae  strains isolated with the eventuality
to modify the antimicrobial protocols used, stool
samples of patients were collected through a
convenience sampling procedure from the 14 CTUs.
Five samples at least were collected each week.
Collection of samples from diagnostically doubtful
cases was encouraged. The stool specimens were
collected from patients in sterile wide mouthed
containers immediately after admission in the CTUs
and prior to the administration of antibiotics and
kept at 4-8ºC in a refrigerated isothermic box. They
were later transferred within 48 hours to the CPC
for culture and antimicrobial drug susceptibility
testing.
In the CPC, V. cholerae was searched for using
conventional techniques including direct
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examination of wet mounts. Gram staining of fixed
smears followed by culture and successive
enrichment on alkaline peptone water. The media
used for the isolation of V. cholerae were thiosulfate
citrate bile salts sucrose agar (TCBS) and gelatine
agar. Hektoin and Muller Kaufman agar were also
used as primary culture media for the isolation of
salmonellae and shigellae. Identification of V. cholera
was based on morphologic, cultural and biochemical
characteristics and its confirmation was based on
an agglutination test using polyvalent 01 serum.
Voges Proskauer (VP) reaction and sensitivity to
polymixine were used to determine the biotype.
The disk-diffusion method recommended by the
“Comité de l’Antbiogramme de la Société Française
de Microbiologie” (10) was used to determine the
susceptibility of the isolated V. cholerae strains to
different antibiotics. The following antibiotics were
tested: amoxicillin, amoxicillin + clavulanic acid,
cefotaxime, chloramphenicol, colistin, doxycycline,
gentamicin, nalidixic acid, perfloxacin, trimethoprim-
sulfamethoxazole and the vibriostatic agent 0/129.
Four per cent of the isolated strains were randomly
selected preserved in a conservation medium
(BioRad, Maine la Coquette, France) and sent to
Institut Pasteur in Paris, France for quality control,
serotyping and coding for the cholera toxin gene and
ribotyping.
RESULTS
A total of 4,941 patients with cholera were registered
over the period of the epidemic. Of the 4,941 patients
2,725 (55 %) were male and 2,196 (45 %) female with
a mean age of 27.9 years (range 1-83 years). All the
patients received antibiotic therapy according to the
standardised treatment guidelines set out at the
onset of the epidemic. Sixty four cases of death were
registered.
Prophylactic antibiotic treatment was given to
15,381 patients’ guards averaging about three
hospital contacts per patient. Visits were made to
the homes of 4,130 (84%) of the 4,941 cholera patients
on the day of or the day after their hospitalisation.
During these home visits a total of 159,263 contacts
(an average of 32 community contacts per case) were
given prophylactic antibiotic treatment. On the
whole, 179,585 curative and prophylactic treatments
were administered over the period of the epidemic.
Table 1 presents details of the numbers of patients
and contacts treated as well as the type of antibiotic
used.
Growth of V. cholerae 01 strains was obtained
from cultures of stool specimens for 81 (57%) of the
141 patients whose stool samples were collected over
the period of the epidemic. The rate of positive stool
specimens for V. cholerae varied from month to
month between 35% and 93% (Figure 1) and between
hospitals from 33% to 71% (data not shown). No
salmonella spp. were isolated but on one sample a
strain of Shigella flexneri was found.
During the entire epidemic, the susceptibility
patterns to antimicrobial drugs of the V. cholerae
strains isolated remained stable. As from the onset
of the outbreak, V. cholerae strains isolated during
the course of the epidemic showed resistance to
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trimethoprim-sulfamethoxazole and colistine,
intermediate resistance to chloramphenicol and
susceptibility to amoxicillin, doxycycline, clavulanic
acid, cefotaxime, doxycycline, gentamicin, nalidixic
acid and perfloxacin.
DISCUSSION
Our case definition of cholera both clinically and
epidemiologically was based on WHO’s (6)
recommendations for cholera epidemics. In order
to ensure accuracy of the clinical diagnosis, the CTUs
were closely monitored. During the epidemic,
exhaustive sampling of cholera cases for
bacteriological confirmation of the diagnosis was
neither possible nor is it recommended (6). Our
sampling strategy however permitted us to monitor
for the presence of V. cholerae in patients’ stools,
ascertain the susceptibility patterns of isolates
obtained to different antibiotics as well as detect
other germs with an epidemic potential throughout
the epidemic. Although the rate of positive samples
may have been greater with better sampling of cases
as well as better conservation and transport
conditions of stool specimens, the presence of V.
cholerae in almost 60% of the samples assured us of
a persisting cholera epidemic. Despite these short-
comings, the positivity rate of our samples was
relatively higher than the 42% and 50% rates
reported in similar studies from Madagascar and
Togo, respectively (11,12).
Routine use of adjunctive antibiotic therapy is
not recommended during cholera epidemics even
though treatment with an effective antimicrobial
drug for cases of suspected cholera with severe
dehydration can be considered good clinical practice
(2). This notwithstanding, we assumed that by
reducing the volume and duration of cholera-related
diarrhoea by antimicrobial therapy, we would
diminish the need for rehydrating with intravenous
fluids, shorten the average hospital stay, and render
the excreta and vomitus of patients manipulated in
our setting mostly by family members less infectious
and consequently less contagious.
Cholera is transmitted by several distinct
mechanisms. The predominant route of transmission
depends largely on the degree of sanitation already
achieved in a given setting. In Douala, attack rates
of cholera were highest in densely populated
precarious sub-urban areas with very poor access
to safe drinking water. Indeed, the only public water
provider in the town serves less than one fifth of
her population. An average household in these
densely populated areas of the town comprises
between seven and ten persons. Very often several
households share the same courtyard, a traditional
kitchen and a pit latrine. The town, besides, does
not dispose of an appropriate sewage drainage
system. More than 90 % of surface water originating
from an intensive nine-months rainy season as well
as waste water from households including that from
latrines is evacuated through a network of open-air
drains formed by the town’s seven small rivers and
their numerous tributaries in a swampy and low
lying terrain that is practically at sea level. Before
arriving in the main drains, the waste water from
several neighbourhoods is channelled and drained
through gutters along narrow foot paths leading to
homes. More than 50% of the population of the town,
composed mostly of young, unemployed and
Table 1
Number of persons treated, type of antibiotic used, and patient-contact ratios
Type of antibiotic
Number of persons treated Doxycycline Amoxicillin (tablets) Amoxicillin (syrup) Total
Patients in CTU 4,506 416  19 4,941
Contacts in CTU 15,239  116 26 15,381
Contacts in the community 143,684 12,425 3,154 159,263
Total number treated 163,429 12,957 3,199 179,585
Ratio contacts/patients 3.1 0.25 1.4 3.1
Ratio community contacts/patients 31.9 29.8 168.6 32.2
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extremely mobile persons, work in the informal
sector and generally eat meals sold along road-sides.
Under these circumstances we assumed that we
could rapidly and efficaciously shorten the period
during which cases and asymptomatic vibrion
carriers could contribute to transmission of the
disease through the ejection of their excreta in an
open and unprotected environment as described
above by giving prophylaxis even though mass
chemoprophylaxis is generally not recommended as
a strategy to control an outbreak of cholera. Two
main reasons are given against the use of
chemoprophylaxis during a cholera outbreak.
Firstly, prophylactic use of antibiotics is believed to
greatly increase the risk of developing drug
resistance by the germs. Secondly, it is doubtful
whether the use of mass chemoprophylaxis is cost-
effective since the period covered by prophylactic
treatment does not exceed 12 days (9). WHO (6),
however, considers that selective chemoprophylaxis
could be potentially useful for close contacts or in
closed populations. We adopted this WHO concept
of selective chemoprophylaxis in the Douala cholera
epidemic but given the town’s environmental and
social context we considered all the inhabitants of a
complex of adjacent households in which a case of
cholera occurred as close contacts. We thought this
approach was reasonable and justified as we gave
chemoprophylaxis as part of a comprehensive
package of community interventions that included
health education, disinfection of latrines and wells
in all the affected households. The success of this
approach depended on pre-set conditions which
included a clear definition of a close contact, prompt
reaction of the intervention teams and rigorous
application and monitoring of prevention
procedures. The fact that the drug susceptibility
patterns of V. cholerae did not change within the
period of the epidemic as feared seems to justify
retrospectively this practical approach.
The dynamics of cholera epidemics depend on
a multitude of factors amongst which are the
virulence of V. cholerae, the environment including
access to clean drinking water and sanitary
infrastructures, the degree of immunity in the
population as well as the behaviour patterns of the
population with regards to personal and nutritional
hygiene and finally prophylactic and therapeutic
interventions. The 2004 cholera epidemic in Douala
lasted 31 weeks and had two epidemic peaks: one
during the dry season at week four and the second,
markedly more intense, during the first period of
the rainy season after 20 weeks. A total of 4,941 cases
were notified, with up to a hundred times more
individuals infected (2). The population at risk when
considering the number of inhabitants in the
neighbourhoods affected was at least four times as
much. Whether the routine use of antimicrobial
therapy and in particular prophylaxis limited the
extent of the cholera epidemic in Douala
substantially is difficult to determine. The context
did not allow a field trial to be conducted with
regards to prophylaxis. This not withstanding, a look
at the dynamics of the present epidemic did not
show any differences neither in its spatial diffusion
and diffusion patterns nor in its seasonal peaking
when compared to the relatively well documented
1997/98 cholera epidemic in the same city. Besides,
characteristics like the relatively low overall attack
rates associated with rather long durations of the
cholera outbreaks was similar to what has been
observed by Legros et al. (12) and Hutin et al. (13) in
other urban settings where systematic prophylaxis
was not applied.
In conclusion, the routine use of antimicrobial
therapy for cholera cases associated with
simultaneous, prolonged, and large scale
chemoprophylaxis of close contacts does not seem
in our experience to compromise the stability of V.
cholerae susceptibility profiles to drugs when applied
within a comprehensive package of rigorously
monitored community interventions. The role of
therapy and chemoprophylaxis in limiting the extent
of a cholera epidemic is however difficult to
ascertain from our experience. Field trials need to
be designed to elucidate this aspect.
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